Overview
- 14 inspections across 14 sites are on record.
- 34 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-07-26.
At a glance
Inspections
14
Sites
14
Observations
34
Career since
Dec 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jubilant HollisterStier LLC | 26 Jul 2019 | Human Drugs | View 483 → |
| ROVI Pharma Industrial Services S.A. | 22 Apr 2016 | Human Drugs | View 483 → |
| HIKMA FARMACEUTICA (PORTUGAL), S.A | 12 Apr 2016 | Human Drugs | View 483 → |
| Orchid Pharma Limited | 4 Sep 2015 | Human Drugs | On file |
| Amneal Pharmaceuticals Private Limited | 25 Aug 2015 | Human Drugs | View 483 → |
Sites inspected
Jubilant HollisterStier LLCSpokane, United States1 insp.
ROVI Pharma Industrial Services S.A.Madrid, Spain1 insp.
HIKMA FARMACEUTICA (PORTUGAL), S.ATerrugem Snt, Portugal1 insp.
Orchid Pharma LimitedKanchipuram, India1 insp.
Amneal Pharmaceuticals Private LimitedAhmedabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Ademola O Daramola2 shared
Linda F Murphy2 shared
Viviana Matta2 shared
Uttaniti Limchumroon2 shared
Myoshi M Francis2 shared
Kristin M Abaonza1 shared
Joey V Quitania1 shared
Melanie M Walker1 shared
Rhonda Alexander1 shared
Dawn M Braswell1 shared
Full investigator report
Get the verbatim findings behind Xiomara Copeland's 34 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site